Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37387 | 1.00 | CYP2C9 (0.50) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| SCHEMBL44299 | 1.00 | CYP2C9 (0.50) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| SCHEMBL299290 | 1.00 | CYP2C9 (0.50) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| SCHEMBL3649734 | 1.00 | CYP2C9 (0.50) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| SCHEMBL37388 | 1.00 | CYP2C9 (0.50) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| SCHEMBL23723109 | 1.00 | CYP2C9 (0.50) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| SCHEMBL31338625 | 1.00 | CYP2C9 (0.50) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| Water SCHEMBL4393893 | 0.97 | CYP2C9 (0.48) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| SCHEMBL30504628 | 0.97 | CYP2C9 (0.48) | CYP2C9TSHRPDE4ALMNAL3MBTL1 | |
| SCHEMBL29825289 | 0.97 | CYP2C9 (0.48) | CYP2C9TSHRPDE4ALMNAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024054682-A2 | ULTRALOW MOLECULAR WEIGHT HEPARIN | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-03-14 | — | — | WO | disclosed |
| US-20240018177-A1 | UTILITY OF NEMATODE SMALL MOLECULES | BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH | 2024-01-18 | — | — | US | disclosed |
| US-11849688-B2 | Compositions and methods for modulating immunity in plants | BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) | 2023-12-26 | — | — | US | disclosed |
| US-11673908-B2 | Utility of nematode small molecules | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2023-06-13 | — | — | US | disclosed |
| US-20230024046-A1 | UTILITY OF NEMATODE SMALL MOLECULES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-01-26 | — | — | US | disclosed |
| US-20220409650-A1 | COMPOSITIONS AND METHODS FOR ASCAROSIDE MODIFICATION OF MAMMALIAN MICROBIOTA | HOLOCLARA INC (US) | 2022-12-29 | — | — | US | disclosed |
| US-20210246476-A1 | BIOSYNTHESIS OF PREPARING NICOTINAMIDE MONONUCLEOTIDE AND DERIVATIVES THEREOF | ZHANG YI HENG PERCIVAL (US) | 2021-08-12 | — | — | US | disclosed |
| US-11019776-B2 | Compositions and methods for modulating immunity in plants | BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) | 2021-06-01 | — | — | US | disclosed |
| US-20210023109-A1 | LIPOTECHOIC ACID FOR IMMUNE MODULATION | NORTHWESTERN UNIVERSITY | 2021-01-28 | — | — | US | disclosed |
| WO-2020247480-A1 | COMPOSITIONS AND METHODS FOR ASCAROSIDE MODIFICATION OF MAMMALIAN MICROBIOTA | HOLOCLARA, INC. (US) | 2020-12-10 | — | — | WO | disclosed |
| EP-1732384-A1 | NOVEL SYNTHETIC C-GLYCOLIPIDS, THEIR SYNTHESIS AND USE TO TREAT INFECTIONS, CANCER AND AUTOIMMUNE DISEASES | NEW YORK UNIVERSITY (US) | 2006-12-20 | — | — | EP | disclosed |
| US-20060019246-A1 | Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases | NEW YORK UNIVERSITY (US) | 2006-01-26 | — | — | US | disclosed |
| WO-2005102049-A1 | NOVEL SYNTHETIC C-GLYCOLIPIDS, THEIR SYNTHESIS AND USE TO TREAT INFECTIONS, CANCER AND AUTOIMMUNE DISEASES | NEW YORK UNIVERSITY (US) | 2005-11-03 | — | — | WO | disclosed |
| US-20050222048-A1 | Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases | THE RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK (US) | 2005-10-06 | — | — | US | disclosed |
| US-20050192248-A1 | Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases | NYU MEDICAL CENTER (US) | 2005-09-01 | — | — | US | disclosed |
| EP-1551228-A2 | SYNTHETIC C-GLYCOLIPID AND ITS USE FOR TREATING CANCER INFECTIOUS DISEASES AND AUTOIMMUNE DISEASES | New York University (US) | 2005-07-13 | — | — | EP | disclosed |
| US-20040127429-A1 | Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases | RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW YORK, THE | 2004-07-01 | — | — | US | disclosed |
| WO-2003105769-A2 | SYNTHETIC C-GLYCOLIPID AND ITS USE FOR TREATING CANCER INFECTIOUS DISEASES AND AUTOIMMUNE DISEASES | NEW YORK UNIVERSITY (US) | 2003-12-24 | — | — | WO | disclosed |
| US-20030162664-A1 | Surfactant coated products and methods for their use in promoting plant growth and soil remediation | JAR-MAR, INC. | 2003-08-28 | — | — | US | disclosed |
| US-6565860-B1 | Agricultural mixtures containing fertilizer | JAY-MAR, INC. | 2003-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162664-A1 | Surfactant coated products and methods for their use in promoting plant growth and soil remediation | GMNN, GHDC, GMDS | CYP2C9 343/4885TSHR 2611/4885PDE4A 2539/4885 |
| US-11019776-B2 | Compositions and methods for modulating immunity in plants | SLC11A2, IFNG, STING1 | CYP2C9 4705/4885TSHR 4608/4885PDE4A 948/4885 |
| US-20230024046-A1 | UTILITY OF NEMATODE SMALL MOLECULES | NOD2, MYD88, NOD1 | CYP2C9 4641/4885TSHR 4770/4885PDE4A 630/4885 |
| US-20240018177-A1 | UTILITY OF NEMATODE SMALL MOLECULES | NOD2, MYD88, NOD1 | CYP2C9 4641/4885TSHR 4770/4885PDE4A 630/4885 |
| US-20050192248-A1 | Use of synthetic glycolipids as universal adjuvants for vaccines against cancer and infectious diseases | CD4, CD81, CD69 | CYP2C9 4431/4885TSHR 3097/4885PDE4A 4177/4885 |
| US-20040127429-A1 | Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases | UGT8, UGCG, SGMS1 | CYP2C9 1453/4885TSHR 467/4885PDE4A 4642/4885 |
| US-20060019246-A1 | Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases | CCR8, UGT8, H1-10 | CYP2C9 1473/4885TSHR 270/4885PDE4A 4653/4885 |
| US-20220409650-A1 | COMPOSITIONS AND METHODS FOR ASCAROSIDE MODIFICATION OF MAMMALIAN MICROBIOTA | SI, FABP2, ALPI | CYP2C9 2291/4885TSHR 4794/4885PDE4A 807/4885 |
| US-20050222048-A1 | Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases | HACD3, SGMS1, UGCG | CYP2C9 2889/4885TSHR 1067/4885PDE4A 3687/4885 |
| US-20210023109-A1 | LIPOTECHOIC ACID FOR IMMUNE MODULATION | LTA, LRBA, LCLAT1 | CYP2C9 4414/4885TSHR 2163/4885PDE4A 2591/4885 |
| US-11849688-B2 | Compositions and methods for modulating immunity in plants | SLC11A2, IFNG, STING1 | CYP2C9 4705/4885TSHR 4608/4885PDE4A 948/4885 |
| US-11673908-B2 | Utility of nematode small molecules | NOD2, MYD88, NOD1 | CYP2C9 4641/4885TSHR 4770/4885PDE4A 630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.